- Previous Close
22.86 - Open
22.89 - Bid 23.33 x --
- Ask 23.34 x --
- Day's Range
22.81 - 23.53 - 52 Week Range
21.18 - 55.95 - Volume
3,057,775 - Avg. Volume
2,565,582 - Market Cap (intraday)
9.651B - Beta (5Y Monthly) 0.02
- PE Ratio (TTM)
23.33 - EPS (TTM)
1.00 - Earnings Date --
- Forward Dividend & Yield 0.15 (0.64%)
- Ex-Dividend Date May 24, 2024
- 1y Target Est
--
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. The company's products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. Changchun BCHT Biotechnology Co. Ltd. was founded in 2004 and is based in Changchun, China.
www.bchtpharm.com1,241
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 688276.SS
View MorePerformance Overview: 688276.SS
Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688276.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688276.SS
View MoreValuation Measures
Market Cap
9.65B
Enterprise Value
9.44B
Trailing P/E
23.33
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.01
Price/Book (mrq)
2.30
Enterprise Value/Revenue
5.87
Enterprise Value/EBITDA
20.03
Financial Highlights
Profitability and Income Statement
Profit Margin
25.77%
Return on Assets (ttm)
5.57%
Return on Equity (ttm)
10.29%
Revenue (ttm)
1.61B
Net Income Avi to Common (ttm)
414.29M
Diluted EPS (ttm)
1.00
Balance Sheet and Cash Flow
Total Cash (mrq)
277.89M
Total Debt/Equity (mrq)
1.49%
Levered Free Cash Flow (ttm)
-303.72M